These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9259173)

  • 21. Propranolol as an antiarrhythmic agent.
    Frieden J
    Am Heart J; 1967 Aug; 74(2):283-5. PubMed ID: 4951306
    [No Abstract]   [Full Text] [Related]  

  • 22. Proarrhythmia in patients treated for atrial fibrillation or flutter.
    Falk RH
    Ann Intern Med; 1992 Jul; 117(2):141-50. PubMed ID: 1605429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmia-Induced Cardiomyopathy.
    Sossalla S; Vollmann D
    Dtsch Arztebl Int; 2018 May; 115(19):335-341. PubMed ID: 29875055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiapamil in the management of supraventricular arrhythmias occurring after acute myocardial infarction.
    Strozzi C; Sfrisi C; Leutenegger F; Padula A; Bulgarelli R
    Cardiology; 1982; 69 Suppl():187-91. PubMed ID: 7151079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry.
    Frommeyer G; Brachmann J; Ince H; Spitzer SG; Thomas D; Willems S; Schumacher B; Schirdewahn P; Lewalter T; Hochadel M; Senges J; Eckardt L
    Clin Res Cardiol; 2019 Oct; 108(10):1083-1092. PubMed ID: 30798346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.
    Obel OA; Camm AJ
    Drugs Aging; 1998 Jun; 12(6):461-76. PubMed ID: 9638394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Catheter ablation of atrial flutter and atrial fibrillation].
    Kobza R; Hindricks G; Kottkamp H
    Ther Umsch; 2004 Apr; 61(4):234-8. PubMed ID: 15137517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a future for antiarrhythmic drug therapy?
    Guerra PG; Talajic M; Roy D; Dubuc M; Thibault B; Nattel S
    Drugs; 1998 Nov; 56(5):767-81. PubMed ID: 9829152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous magnesium for the treatment of cardiac arrhythmias.
    Arnold DJ
    Aust N Z J Med; 2000 Feb; 30(1):54-60. PubMed ID: 10800879
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of SU 13197, a new antiarrhythmic agent, on atrial arrhythmias: preliminary study.
    Dreifus LS; Lim HF; Rabbino MD; Watanabe Y
    Am J Cardiol; 1968 Apr; 21(4):544-8. PubMed ID: 5645997
    [No Abstract]   [Full Text] [Related]  

  • 37. Peri-operative supraventricular arrhythmias in coronary bypass surgery.
    Yousif H; Davies G; Oakley CM
    Int J Cardiol; 1990 Mar; 26(3):313-8. PubMed ID: 2312199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["Arrhythmica" or: history, extent and practical consequences of pro-arrhythmia effects].
    Gertsch M
    Schweiz Med Wochenschr; 1996 Apr; 126(14):566-75. PubMed ID: 8668970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.